BI Asset Management Fondsmaeglerselskab A S grew its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 26.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,663 shares of the financial services provider's stock after buying an additional 5,815 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in MetLife were worth $2,265,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of MET. Anchor Investment Management LLC boosted its position in shares of MetLife by 12.5% during the third quarter. Anchor Investment Management LLC now owns 6,115 shares of the financial services provider's stock worth $504,000 after purchasing an additional 681 shares in the last quarter. World Investment Advisors LLC acquired a new stake in shares of MetLife during the third quarter worth about $336,000. Wilmington Savings Fund Society FSB acquired a new position in shares of MetLife in the 3rd quarter valued at approximately $701,000. Tidal Investments LLC lifted its stake in MetLife by 3.9% in the third quarter. Tidal Investments LLC now owns 19,282 shares of the financial services provider's stock valued at $1,590,000 after buying an additional 718 shares in the last quarter. Finally, Synovus Financial Corp increased its position in shares of MetLife by 5.5% during the third quarter. Synovus Financial Corp now owns 22,720 shares of the financial services provider's stock worth $1,874,000 after acquiring an additional 1,183 shares in the last quarter. 94.99% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have issued reports on MET. Keefe, Bruyette & Woods lowered their target price on MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Piper Sandler boosted their target price on MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Wells Fargo & Company lowered their price objective on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. BMO Capital Markets initiated coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price target on the stock. Finally, Barclays lowered their target price on MetLife from $95.00 to $88.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $92.46.
View Our Latest Stock Analysis on MetLife
MetLife Trading Down 3.0 %
Shares of MET stock opened at $70.38 on Tuesday. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The firm has a 50 day moving average price of $78.94 and a two-hundred day moving average price of $82.04. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $47.94 billion, a PE ratio of 11.79, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.